(19)

(11)

EP 4 106 732 A1

(12)

(43) Date of publication: 28.12.2022 Bulletin 2022/52 (21) Application number: 21705529.2 (22) Date of filing: 17.02.2021

(51) International Patent Classification (IPC):  A61K 9/16(2006.01) A61K 9/48(2006.01) A61P 5/50(2006.01) A61K 9/20(2006.01) A61K 31/70(2006.01) A61K 31/155(2006.01) (52) Cooperative Patent Classification (CPC): A61K 9/1652; A61K 9/1611; A61K 9/2054; A61K 9/4866; A61K 31/70; A61P 5/50 (86) International application number: PCT/EP2021/053880 (87) International publication number: WO 2021/165316 (26.08.2021 Gazette 2021/34)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME Designated Validation States: KH MA MD TN (30) Priority: 21.02.2020 EP 20460013 (71) Applicant: Zaklady Farmaceutyczne Polpharma S.A. 83-200 Starogard Gdanski (PL)	(72) Inventors: KACZMAREK, Mateusz 63-400 Ostrów Wielkopolski (PL) PRZERADA, Szymon 83-200 Starogard Gda ski (PL) HRAKOVSKY, Julia 80-862 Gda sk (PL) DZIK, Jakub 83-200 Starogard Gda ski (PL) (74) Representative: Elkington and Fife LLP  Prospect House 8 Pembroke Road Sevenoaks, Kent TN13 1XR Sevenoaks, Kent TN13 1XR (GB)